{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:59:18Z","timestamp":1791118758623,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,12]],"date-time":"2012-05-12T00:00:00Z","timestamp":1336780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00404-012-2371-x","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T06:45:34Z","timestamp":1336718734000},"page":"637-642","source":"Crossref","is-referenced-by-count":28,"title":["Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy"],"prefix":"10.1007","volume":"286","author":[{"given":"Stefano R.","family":"Giannubilo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Bezzeccheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Landi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna I.","family":"Battistoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Tranquilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,12]]},"reference":[{"key":"2371_CR1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0029-7844(95)00480-7","volume":"87","author":"AR Samadi","year":"1996","unstructured":"Samadi AR, Mayberry RM, Zaidi AA, Pleasant JC, McGhee N Jr, Rice RJ (1996) Maternal hypertension and associated pregnancy complications among African-American and other women in the United States. Obstet Gynecol 87:557\u2013563","journal-title":"Obstet Gynecol"},{"key":"2371_CR2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-199121040-00001","volume":"21","author":"C Knott","year":"1991","unstructured":"Knott C (1991) The treatment of hypertension in pregnancy. Clinical pharmacokinetic considerations. Clin Pharmacokinet 21:233\u2013241","journal-title":"Clin Pharmacokinet"},{"key":"2371_CR3","first-page":"CD002252","volume":"24","author":"E Abalos","year":"2007","unstructured":"Abalos E, Duley L, Steyn DW, Henderson-Smart DJ (2007) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 24:CD002252","journal-title":"Cochrane Database Syst Rev"},{"key":"2371_CR4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0029-7844(03)00475-7","volume":"102","author":"BM Sibai","year":"2003","unstructured":"Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102:181\u2013192","journal-title":"Obstet Gynecol"},{"key":"2371_CR5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","volume":"183","author":"Report of the National High Blood Pressure Education Program","year":"2000","unstructured":"Report of the National High Blood Pressure Education Program, Working group report on high blood pressure in pregnancy (2000) Am J Obstet Gynecol 183:S1\u2013S22","journal-title":"Am J Obstet Gynecol"},{"key":"2371_CR6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1479-828X.2000.tb01136.x","volume":"40","author":"MA Brown","year":"2000","unstructured":"Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, Peek MJ, Rowan JA, Walters BN, Austalasian Society of the Study of Hypertension in Pregnancy (2000) The detection, investigation and management of hypertension in pregnancy: executive summary. Aust NZ J Obstet Gynaecol 40:133\u2013138","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"2371_CR7","first-page":"1245","volume":"157","author":"E Rey","year":"1997","unstructured":"Rey E, LeLorier J, Burgess E, Lange IR, Leduc L (1997) Report of the Canadian Hypertension Society consensus conference: Pharmacologic treatment of hypertensive disorders in pregnancy. Can Med Assoc J 157:1245\u20131254","journal-title":"Can Med Assoc J"},{"key":"2371_CR8","first-page":"128","volume":"78","author":"M Hanssens","year":"1991","unstructured":"Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA (1991) Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 78:128\u2013135","journal-title":"Obstet Gynecol"},{"key":"2371_CR9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1471-0528.1993.tb14242.x","volume":"100","author":"JG Thorpe-Beeston","year":"1993","unstructured":"Thorpe-Beeston JG, Armar NA, Dancy M, Cochrane GW, Ryan G, Rodeck CH (1993) Pregnancy and ACE inhibitors. Br J Obstet Gynaecol 100:692\u2013693","journal-title":"Br J Obstet Gynaecol"},{"key":"2371_CR10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0002-9378(62)90069-8","volume":"84","author":"CE Flowers","year":"1962","unstructured":"Flowers CE, Grizzle JE, Easterling WE, Bonner OB (1962) Chlorthiazide as a prophylaxis against toxemia of pregnancy. Am J Obstet Gynecol 84:919\u2013929","journal-title":"Am J Obstet Gynecol"},{"key":"2371_CR11","volume-title":"Medical disorders in pregnancy","author":"MD Lindheimer","year":"2000","unstructured":"Lindheimer MD, Barron WM (2000) Medical disorders in pregnancy. Mosby, St. Louis"},{"key":"2371_CR12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1471-0528.2000.tb13222.x","volume":"107","author":"P Smith","year":"2000","unstructured":"Smith P, Anthony J, Johanson R (2000) Nifedipine in pregnancy. Br J Obstet Gynaecol 107:299\u2013307","journal-title":"Br J Obstet Gynaecol"},{"key":"2371_CR13","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1471-0528.2000.tb13342.x","volume":"107","author":"R Bortolus","year":"2000","unstructured":"Bortolus R, Ricci E, Chatenoud L, Parazzini F (2000) Nifedipine administered in pregnancy: effect on the development of children at 18\u00a0months. BJOG 107:792\u2013794","journal-title":"BJOG"},{"key":"2371_CR14","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.2174\/092986709789057699","volume":"16","author":"AL Tranquilli","year":"2009","unstructured":"Tranquilli AL, Giannubilo SR (2009) Use and safety of calcium channel blockers in obstetrics. Curr Med Chem 16:3330\u20133340","journal-title":"Curr Med Chem"},{"key":"2371_CR15","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/HYPERTENSIONAHA.106.075895","volume":"51","author":"T Podymow","year":"2008","unstructured":"Podymow T, August P (2008) Update on the use of antihypertensive drugs in pregnancy. Hypertension 51:960\u2013969","journal-title":"Hypertension"},{"key":"2371_CR16","volume-title":"Drugs in pregnancy and lactation","author":"GG Briggs","year":"1994","unstructured":"Briggs GG, Freeman RK, Yae SJ (1994) Drugs in pregnancy and lactation. Williams & Wilkins, Baltimore"},{"key":"2371_CR17","first-page":"9","volume":"20","author":"MA Brown","year":"2001","unstructured":"Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM (2001) The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hyper Pregnancy 20:9\u201314","journal-title":"Hyper Pregnancy"},{"key":"2371_CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0029-7844(01)01747-1","volume":"99","author":"ACOG Committee on Practice Bulletins-Obstetrics","year":"2002","unstructured":"ACOG Committee on Practice Bulletins-Obstetrics (2002) Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 99:159\u2013167","journal-title":"Obstet Gynecol"},{"key":"2371_CR19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9378(86)90266-8","volume":"155","author":"BM Sibai","year":"1986","unstructured":"Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM (1986) Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 155:501\u2013509","journal-title":"Am J Obstet Gynecol"},{"key":"2371_CR20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1515\/jpme.1986.14.2.101","volume":"14","author":"U Nicolini","year":"1986","unstructured":"Nicolini U, Ferrazzi E, Molla R, Massa E, Cicognani G, Santarone M, Bellotti M, Pardi G (1986) Accuracy of an average ultrasonic laboratory in measurements of fetal biparietal diameter, head circumference and abdominal circumference. J Perinat Med 14:101\u2013107","journal-title":"J Perinat Med"},{"key":"2371_CR21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/00365518409085385","volume":"169","author":"K Wichman","year":"1984","unstructured":"Wichman K, Ryden G, Karlberg BE (1984) A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Scand J Clin Lab Invest 169:90\u201394","journal-title":"Scand J Clin Lab Invest"},{"key":"2371_CR22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000300984","volume":"9","author":"B Sandstrom","year":"1978","unstructured":"Sandstrom B (1978) Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy. Gynecol Obstet Invest 9:195\u2013204","journal-title":"Gynecol Obstet Invest"},{"key":"2371_CR23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/bmj.291.6495.563","volume":"291","author":"EDM Gallery","year":"1985","unstructured":"Gallery EDM, Ross ME, Gyory AZ (1985) Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. BMJ 291:563\u2013566","journal-title":"BMJ"},{"key":"2371_CR24","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1136\/bmj.286.6382.1927","volume":"286","author":"J Fidler","year":"1983","unstructured":"Fidler J, Smith V, Fayers P, De Swiet M (1983) Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. BMJ 286:1927\u20131930","journal-title":"BMJ"},{"key":"2371_CR25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-0528.1990.tb01738.x","volume":"97","author":"PF Plouin","year":"1990","unstructured":"Plouin PF, Breart G, Llado J, Dalle M, Keller ME, Goujon H, Berchel C (1990) A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancyinduced hypertension. Br J Obstet Gynaecol 97:134\u2013141","journal-title":"Br J Obstet Gynaecol"},{"key":"2371_CR26","first-page":"323","volume":"70","author":"BM Sibai","year":"1987","unstructured":"Sibai BM, Gonzalez AR, Mabie WC, Morettini M (1987) A comparison of labetalol plus hospitalisation versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 70:323\u2013327","journal-title":"Obstet Gynecol"},{"key":"2371_CR27","first-page":"1366","volume":"355","author":"LA Magee","year":"2000","unstructured":"Magee LA (2000) Fetal growth restriction. Lancet 355:1366\u20131372","journal-title":"Lancet"},{"key":"2371_CR28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bmj.301.6752.587","volume":"301","author":"L Butters","year":"1990","unstructured":"Butters L, Kennedy S, Rubin PC (1990) Atenolol in essential hypertension during pregnancy. Br Med J 301:587\u2013589","journal-title":"Br Med J"},{"key":"2371_CR29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0895-7061(99)00031-X","volume":"12","author":"C Lydakis","year":"1999","unstructured":"Lydakis C, Lip GYH, Beevers M, Beevers DG (1999) Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 12:541\u2013547","journal-title":"Am J Hypertens"},{"key":"2371_CR30","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0002-9149(97)00163-X","volume":"79","author":"GY Lip","year":"1997","unstructured":"Lip GY, Beevers M, Churchill D, Shaffer LM, Beevers DG (1997) Effects of atenolol on birth weight. Am J Cardiol 79:1436\u20131438","journal-title":"Am J Cardiol"},{"key":"2371_CR31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0029-7844(98)00522-5","volume":"93","author":"TR Easterling","year":"1999","unstructured":"Easterling TR, Brateng D, Schmucker B, Brown Z, Millard SP (1999) Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Obstet Gynecol 93:725\u2013733","journal-title":"Obstet Gynecol"},{"key":"2371_CR32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0028-2243(92)90192-2","volume":"45","author":"DJ Cruickshank","year":"1992","unstructured":"Cruickshank DJ, Robertson AA, Campbell DM, MacGillivray I (1992) Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomized controlled study. Eur J Obstet Gynecol Reprod Biol 45:47\u201351","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2371_CR33","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1471-0528.1988.tb06571.x","volume":"95","author":"PF Plouin","year":"1988","unstructured":"Plouin PF, Breart G, Maillard F, Papiernik E, Relier JP (1988) Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomised controlled trial. Br J Obstet Gynaecol 95:868\u2013876","journal-title":"Br J Obstet Gynaecol"},{"key":"2371_CR34","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0002-9378(90)91297-P","volume":"162","author":"BM Sibai","year":"1990","unstructured":"Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD (1990) A comparison of no medication vs methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 162:960\u2013967","journal-title":"Am J Obstet Gynecol"},{"key":"2371_CR35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1471-0528.1989.tb01574.x","volume":"96","author":"CJ Pickles","year":"1989","unstructured":"Pickles CJ, Symonds EM, Pipkin FB (1989) The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol 96:38\u201343","journal-title":"Br J Obstet Gynaecol"},{"key":"2371_CR36","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0002-9378(84)90458-7","volume":"150","author":"BM Sibai","year":"1984","unstructured":"Sibai BM, Grossman RA, Grossman HG (1984) Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol 150:831\u2013835","journal-title":"Am J Obstet Gynecol"},{"key":"2371_CR37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1471-0528.1975.tb00689.x","volume":"82","author":"DM Campbell","year":"1975","unstructured":"Campbell DM, MacGillivray I (1975) The effect of a low calorie diet or a thiazide diuretic on the incidence of pre-eclampsia and on birthweight. Br J Obstet Gynecol 82:572\u2013577","journal-title":"Br J Obstet Gynecol"},{"key":"2371_CR38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0029-7844(01)01477-6","volume":"98","author":"TR Easterling","year":"2001","unstructured":"Easterling TR, Carr DB, Brateng D, Diederichs C, Schmucker B (2001) Obstet Gynecol 98:427\u2013433","journal-title":"Obstet Gynecol"},{"key":"2371_CR39","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9378(96)70307-1","volume":"174","author":"LA Magee","year":"1996","unstructured":"Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L, McElhatton PR, Schmidt MA, Koren G (1996) The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 174:823\u2013828","journal-title":"Am J Obstet Gynecol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-012-2371-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-012-2371-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-012-2371-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:56:33Z","timestamp":1559051793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-012-2371-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,12]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["2371"],"URL":"https:\/\/doi.org\/10.1007\/s00404-012-2371-x","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,12]]}}}